In this episode, Sidney Ocanagil-Tunstall visits the Cancer Research UK Cambridge Institute to explore how digital pathology and spatial biology are transforming cancer research.

Joined by Dr Julia Jones, Scientific Manager for In Situ Hybridisation, alongside Senior Scientific Associates Elsa Santos and Cara Brodie, the conversation examines the Institute’s long-standing commitment to innovation, from early adoption of digital pathology workflows to the integration of advanced spatial omics technologies.

The discussion covers image analysis, multiplex assays, multimodal approaches combining RNA and protein detection, and the growing role of spatial biology in understanding the tumour microenvironment. The team also reflects on the practical challenges of implementation, including costs, technology selection, collaboration, and the importance of shared expertise in driving the next generation of cancer research.